TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE SYSTEM
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISE IN THE NUMBER OF STRATEGIC INITIATIVES
4.2.2 BENEFITS ASSOCIATED WITH PHARMACY MANAGEMENT SYSTEMS
4.2.3 BURDEN ON PHARMACISTS DUE TO INCREASING NUMBER OF PRESCRIPTIONS
4.3 RESTRAINTS
4.3.1 COMPLEX FEATURES SUCH AS VENDOR LOCK-IN
4.4 OPPORTUNITIES
4.4.1 INCREASING DEMAND FOR PHARMACY MANAGEMENT SYSTEMS IN EMERGING ECONOMIES
4.5 CHALLENGES
4.5.1 UNAVAILABILITY OF TRAINED PROFESSIONALS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 INPUTS
5.1.2 SOFTWARE DEVELOPMENT PROCESSES
5.1.3 OUTPUT
5.1.4 MARKETING AND DISTRIBUTION
5.1.5 POST-SELLING SERVICES
5.1.5.1 SOFTWARE MAINTENANCE SERVICES & AGREEMENTS
5.1.5.2 TRAINING & CERTIFICATIONS
5.1.5.3 SUPPORT: TECHNICAL & GRIEVANCE AID
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE PHARMACY MANAGEMENT SYSTEM MARKET
6 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE
6.1 OVERVIEW
6.2 PHARMACY INVENTORY MANAGEMENT SYSTEM
6.3 PHARMACY DATA MANAGEMENT SYSTEM
6.4 PHARMACY COMPOUNDING SOFTWARE SYSTEM
6.5 PHARMACY BENEFITS MANAGEMENT SYSTEM
6.6 PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM
6.7 OTHERS
7 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SOFTWARE
7.3 HARDWARE
7.4 SERVICES
8 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE
8.1 OVERVIEW
8.2 CLOUD/WEB-BASED
8.3 ON-PREMISE
9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER
9.1 OVERVIEW
9.2 INPATIENT PHARMACIES
9.3 OUTPATIENT PHARMACIES
10 PHARMACY MANAGEMENT SYSTEMS, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 NETHERLANDS
10.3.1.7 SWITZERLAND
10.3.1.8 BELGIUM
10.3.1.9 AUSTRIA
10.3.1.10 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 TAIWAN
10.4.7 NEW ZEALAND
10.4.8 THAILAND
10.4.9 PHILIPPINES
10.4.10 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 MERGER & ACQUISITIONS
11.6.3 AGREEMENT/MARKETING STRATEGIES
12 COMPANY PROFILES
12.1 ALLSCRIPTS HEALTHCARE, LLC
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 CERNER CORPORATION
12.2.1 COMPANY OVERVIEW
12.2.2 PRODUCTS OFFERED
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 DATASCAN PHARMACY
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 EPICOR SOFTWARE CORPORATION
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 GLOBEMED GROUP
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 LIBERTY SOFTWARE, INC.
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 LS RETAIL EHF
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 MCKESSON CORPORATION
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 MEDHOK, INC.
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 OCTAL IT SOLUTION LLP
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
12.11 SAFECARE TECHNOLOGY
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 KEY STRATEGIES
12.12 SCRIPTPRO LLC
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 KEY STRATEGIES
12.13 CLANWILLIAM HEALTH
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 PRODUCTS OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 KEY STRATEGIES
12.14 MOBILE MEDSOFT
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 PRODUCTS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 KEY STRATEGIES
12.15 HEALTH BUSINESS SYSTEMS, INC.
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 PRODUCTS OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY INVENTORY MANAGEMENT SYSTEM, BY REGION, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY DATA MANAGEMENT SYSTEM, BY REGION, 2023-2030 (USD MILLION)
TABLE 6 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY COMPOUNDING SOFTWARE SYSTEM, BY REGION, 2023-2030 (USD MILLION)
TABLE 7 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMA PHARMACY BENEFITS MANAGEMENT SYSTEM, BY REGION, 2023-2030 (USD MILLION)
TABLE 8 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM, BY REGION, 2023-2030 (USD MILLION)
TABLE 9 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
TABLE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2023-2030 (USD MILLION)
TABLE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 14 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 15 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR CLOUD/WEB-BASED, BY REGION, 2023-2030 (USD MILLION)
TABLE 16 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR ON-PREMISE, BY REGION, 2023-2030 (USD MILLION)
TABLE 17 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 18 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 19 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 20 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 21 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2023-2030 (USD MILLION)
TABLE 22 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 23 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 24 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 25 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 26 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 27 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 28 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 29 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 34 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 35 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 36 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 37 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 38 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 39 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 40 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 41 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 42 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 43 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 44 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 45 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 46 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 47 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 48 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 49 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 50 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 51 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 52 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 53 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 54 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 55 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 56 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 57 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 58 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 59 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 60 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 61 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 62 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 63 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 64 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 65 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 66 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 67 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 68 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 69 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 70 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 71 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 72 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 73 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 74 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 75 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 76 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 77 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 78 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 79 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 80 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 81 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 82 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 83 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 84 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 85 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 86 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 87 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 88 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 89 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 90 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 91 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 92 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 93 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 94 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 95 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 96 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 97 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 98 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 99 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 100 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 101 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 102 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 103 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 104 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 105 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 106 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 107 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 108 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 109 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 110 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 111 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 112 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 113 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 114 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 115 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 116 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 117 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 118 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 119 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 120 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 121 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 122 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 123 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 124 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 125 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 126 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 127 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 128 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2023-2030 (USD MILLION)
TABLE 129 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 130 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 136 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 137 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 138 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 139 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 140 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 141 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 142 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 143 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 144 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 145 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 146 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 147 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 148 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 149 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 150 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 151 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 152 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 153 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 154 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 155 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 156 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 157 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 158 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 159 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 160 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 161 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 162 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 163 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 164 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 165 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 166 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 167 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 168 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 169 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 170 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 171 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 172 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 173 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 174 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 175 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 176 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 177 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 178 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 179 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 180 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 181 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 182 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 183 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 184 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 185 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 186 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 187 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 188 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 189 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 190 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 191 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 192 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 193 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 194 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 195 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 203 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 204 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 205 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 206 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 207 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 208 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 209 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2023-2030 (USD MILLION)
TABLE 210 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2023-2030 (USD MILLION)
TABLE 211 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
TABLE 212 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2023-2030 (USD MILLION)
TABLE 213 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 214 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2023-2030 (USD MILLION)
TABLE 215 MAJOR PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
TABLE 216 MOST ACTIVE PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
TABLE 217 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 218 MERGER & ACQUISITIONS
TABLE 219 AGREEMENT/MARKETING STRATEGIES
TABLE 220 ALLSCRIPTS HEALTHCARE, LLC: SERVICES OFFERED
TABLE 221 ALLSCRIPTS HEALTHCARE, LLC: KEY DEVELOPMENTS
TABLE 222 CERNER CORPORATION: PRODUCTS OFFERED
TABLE 223 DATASCAN PHARMACY: PRODUCTS OFFERED
TABLE 224 EPICOR SOFTWARE CORPORATION: PRODUCTS OFFERED
TABLE 225 GLOBEMED GROUP: PRODUCTS OFFERED
TABLE 226 LIBERTY SOFTWARE, INC.: PRODUCTS OFFERED
TABLE 227 LS RETAIL EHF.: PRODUCTS OFFERED
TABLE 228 MCKESSON CORPORATION: PRODUCTS OFFERED
TABLE 229 MCKESSON CORPORATION: KEY DEVELOPMENTS
TABLE 230 MEDHOK, INC.: PRODUCTS OFFERED
TABLE 231 OCTAL IT SOLUTION LLP.: PRODUCTS OFFERED
TABLE 232 SAFECARE TECHNOLOGY: PRODUCTS OFFERED
TABLE 233 SCRIPTPRO LLC: PRODUCTS OFFERED
TABLE 234 CLANWILLIAM HEALTH: PRODUCTS OFFERED
TABLE 235 CLANWILLIAM HEALTH: KEY DEVELOPMENTS
TABLE 236 MOBILE MEDSOFT: PRODUCTS OFFERED
TABLE 237 HEALTHCARE BUSINESS SYSTEMS, INC.: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2021 & 2030 (USD MILLION)
FIGURE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2021 & 2030 (USD MILLION)
FIGURE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2021 & 2030 (USD MILLION)
FIGURE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2021 & 2030 (USD MILLION)
FIGURE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET SHARE (%), BY REGION, 2021
FIGURE 14 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 15 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 16 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 17 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
FIGURE 18 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
FIGURE 19 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
FIGURE 22 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET: COMPETITIVE LANDSCAPE
FIGURE 23 ALLSCRIPTS HEALTHCARE, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ALLSCRIPTS HEALTHCARE, LLC: SWOT ANALYSIS
FIGURE 25 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 CERNER CORPORATION: SWOT ANALYSIS
FIGURE 27 EPICOR SOFTWARE CORPORATION: SWOT ANALYSIS
FIGURE 28 GLOBEMED GROUP: SWOT ANALYSIS
FIGURE 29 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 MCKESSON CORPORATION: SWOT ANALYSIS